Perirenalfat thickness is associated with bone turnover markers and bone mineral density in postmenopausal women with type 2 diabetes mellitus

Perirenalfat thickness is associated with bone turnover markers and bone mineral density in postmenopausal women with type 2 diabetes mellitus

ObjectivesEmerging evidence demonstrated that perirenal fat may modulate bone metabolism through several pathological pathways. This study was aimed to assess the associations between perirenal fat thickness (PrFT) and bone turnover markers (BTMs) and bone mineral density (BMD) in postmenopausal wom...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Wei Wang, Rong Huang, Ping Tai Tang, Mei Tu, Xiu Li Guo
Formato:	Artigo
Idioma:	English
Publicado em:	Frontiers Media S.A. 2022-10-01
Colecção:	Frontiers in Endocrinology
Assuntos:	bone turnover markers bone mineral density postmenopausal women type 2 diabetes mellitus perirenal fat thickness
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fendo.2022.990667/full

Registos relacionados

Association of Serum Periostin Level with Classical Bone Turnover Markers and Bone Mineral Density in Shanghai Chinese Postmenopausal Women with Osteoporosis
Por: Li R, et al.
Publicado em: (2021-11-01)

Bone Turnover in Postmenopausal Women with Bone Loss - Original Investigation
Por: Nurdan Paker, et al.
Publicado em: (2005-12-01)

Changes of bone turnover markers and bone mineral density among postmenopausal Thai women with osteoporosis receiving generic risedronate
Por: Ammarin Suwan, et al.
Publicado em: (2024-10-01)

The relationships between bone turnover markers and bone mineral density in postmenopausal type 2 diabetic women
Por: Vadim V. Klimontov, et al.
Publicado em: (2016-11-01)

Relationship of Body Mass Index, Bone Turnover Marker and Bone Mineral Density in Postmenopausal Women
Por: Shehla Shaheen, et al.
Publicado em: (2015-09-01)

Vitamin D status and its associations with bone mineral density, bone turnover markers, and parathyroid hormone in Chinese postmenopausal women with osteopenia and osteoporosis
Por: Xi Chen, et al.
Publicado em: (2024-01-01)

Evaluation of bone remodelling parameters after one year treatment with alendronate in postmenopausal women with osteoporosis
Por: Elma Kučukalić-Selimović, et al.
Publicado em: (2011-02-01)

The Relationship Between the FRAX Tool and Bone Turnover Markers in Postmenopausal Osteoporosis
Por: Murat Uludağ, et al.
Publicado em: (2013-08-01)

Bone turnover markers relations to postmenopausal osteoporosis
Por: Mečevska-Jovčevska Jasmina, et al.
Publicado em: (2009-01-01)

Bone turnover markers: Emerging tool in the management of osteoporosis
Por: Sahana Shetty, et al.
Publicado em: (2016-01-01)

High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis
Por: Ishikawa K, et al.
Publicado em: (2016-12-01)

The correlation between coagulation biomarkers, bone turnover markers, and bone mineral density in Chinese adults aged ≥ 50 years
Por: Zhengming Wang, et al.
Publicado em: (2024-03-01)

Bone remodeling in patients with type I and type II diabetes mellitus in pre- and postmenopausal periods
Por: S. S. Safarova, et al.
Publicado em: (2020-11-01)

Effects of probiotic supplementation on bone health in postmenopausal women: a systematic review and meta-analysis
Por: Fang Wang, et al.
Publicado em: (2024-11-01)

Serum bone alkaline phosphatase is a useful marker to evaluate lumbar bone mineral density in Japanese postmenopausal osteoporotic women during denosumab treatment
Por: Nakamura Y, et al.
Publicado em: (2017-10-01)

Kinetic of bone turnover markers after osteoporotic vertebral compression fractures in postmenopausal female
Por: Changyu Pan, et al.
Publicado em: (2018-12-01)

BONE TURNOVER AND MINERAL DENSITY OF THE LUMBAR VERTEBRAE IN WOMEN WITH PRIMARY BILIARY CIRRHOSIS BEFORE AND AFTER ORTHOTOPIC LIVER TRANSPLANTATION
Por: I. A. Pronchenko, et al.
Publicado em: (2013-03-01)

Association between bone turnover markers, bone mineral density, and serum osteoglycine in middle-aged men with Type 2 Diabetes mellitus
Por: Salma Mohamed Mostafa, et al.
Publicado em: (2024-07-01)

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
Por: Mederle OA, et al.
Publicado em: (2018-08-01)

Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis
Por: Mingwei Hu, et al.
Publicado em: (2023-07-01)

The Association Between Bone Mineral Density and Biochemical Bone Turnover Markers in Women at Thapho District, Phitsanulok Province
Por: Pachuen Potup, et al.
Publicado em: (2014-04-01)

The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
Por: S. Akı, et al.
Publicado em: (2002-03-01)

Role of Soy Protein on Bone Turnover
Por: A Haghighian roudsari, et al.
Publicado em: (2004-03-01)

Role of Soy Protein on Bone Turnover
Por: A Haghighian roudsari, et al.
Publicado em: (2004-11-01)

A randomized placebo-controlled trial of the efficacy of denosumab in Indian postmenopausal women with osteoporosis
Por: Shailesh Pitale, et al.
Publicado em: (2015-01-01)

Bone Turnover Markers and Bone Mineral Density to Predict Osteoporotic Fractures in Older Women: A Retrospective Comparative Study
Por: Xiao‐long Qu, et al.
Publicado em: (2020-02-01)

Diabetes, biochemical markers of bone turnover, diabetes control and bone
Por: Jakob eStarup-Linde, et al.
Publicado em: (2013-03-01)

Associations of Serum Cathepsin K and Polymorphisms in CTSK Gene With Bone Mineral Density and Bone Metabolism Markers in Postmenopausal Chinese Women
Por: Li-hong Gao, et al.
Publicado em: (2020-02-01)

The effect of short-term low-energy ultraviolet B irradiation on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis: A randomized single-blinded controlled clinical trial
Por: Micić Ivan, et al.
Publicado em: (2013-01-01)

Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial
Por: Andre Gustavo Daher Vianna, et al.
Publicado em: (2017-05-01)

Relationship Between Bone Turnover and Bone Density in Perimenopausal and Early Postmenopausal Women - Original Investigation
Por: Nurdan Paker, et al.
Publicado em: (2009-04-01)

Impact of hydrocortisone replacement on bone mineral density and bone turnover markers in patients with primary adrenal insufficiency
Por: Yazidi Meriem, et al.
Publicado em: (2022-07-01)

Undercarboxylated Osteocalcin and Its Associations With Bone Mineral Density, Bone Turnover Markers, and Prevalence of Osteopenia and Osteoporosis in Chinese Population: A Cross-Sectional Study
Por: Yang Xu, et al.
Publicado em: (2022-07-01)

The State of Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes Mellitus
Por: M.L. Kyryliuk, et al.
Publicado em: (2016-11-01)

Apolipoprotein A1 is associated with osteocalcin and bone mineral density rather than high-density lipoprotein cholesterol in Chinese postmenopausal women with type 2 diabetes mellitus
Por: Wei Wang, et al.
Publicado em: (2023-06-01)

Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis
Por: Giovanni Adami, et al.
Publicado em: (2024-09-01)

The Comparison of Bone Mineral Density Between Postmenopausal Women and Elderly Women
Por: Bülent Çakmak, et al.
Publicado em: (2012-12-01)

The correlation of two bone turnover markers with bone mineral density: a population-based cross-sectional study
Por: Gao-Xiang Wang, et al.
Publicado em: (2023-08-01)

The use of bone turnover markers for monitoring the treatment of osteoporosis in postmenopausal females undergoing total knee arthroplasty: a prospective randomized study
Por: Rui Ma, et al.
Publicado em: (2021-03-01)

The influence of vegan diet on bone mineral density and biochemical bone turnover markers
Por: Jadwiga Ambroszkiewicz, et al.
Publicado em: (2010-09-01)